Royal Bank Of Canada Sangamo Therapeutics, Inc Transaction History

Royal Bank Of Canada

$425 Billion
Q2 2024

A detailed history of Royal Bank Of Canada transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 13,094 shares of SGMO stock, worth $11,391. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,094

Previous 6,077 115.47%

Holding current value

$11,391

Previous $4,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.36 - $0.65 $2,526 - $4,561	7,017 Added 115.47%	13,094 $4,000
Q1 2024 May 15, 2024	SELL	$0.42 - $1.38 $21,493 - $70,620	-51,174 Reduced 89.39%	6,077 $4,000
Q4 2023 Feb 14, 2024	SELL	$0.3 - $0.63 $24,241 - $50,907	-80,806 Reduced 58.53%	57,251 $30,000
Q3 2023 Nov 14, 2023	SELL	$0.58 - $1.47 $52,005 - $131,807	-89,665 Reduced 39.37%	138,057 $82,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $1.74 $106,635 - $167,158	96,068 Added 72.97%	227,722 $296,000
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $156,503 - $346,003	94,279 Added 252.25%	131,654 $231,000
Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $22,835 - $41,797	8,244 Added 28.3%	37,375 $117,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $12,540 - $18,767	2,937 Added 11.21%	29,131 $144,000
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.21 $22,153 - $41,942	-6,754 Reduced 20.5%	26,194 $109,000
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $88,193 - $131,868	-16,863 Reduced 33.85%	32,948 $190,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $59,078 - $88,900	8,104 Added 19.43%	49,811 $374,000
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $5,811 - $7,746	645 Added 1.57%	41,707 $375,000
Q2 2021 Aug 16, 2021	BUY	$10.17 - $12.64 $417,600 - $519,023	41,062 New	41,062 $492,000

Others Institutions Holding SGMO

# of Institutions

133

Shares Held

86.3M

Call Options Held

35.9K

Put Options Held

156K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Sangamo Therapeutics, Inc Transaction History